Blood cell and/or bone marrow transplant is conducted for certain life-threatening diseases and blood cancers. Transplant involves obliterating the bone marrow followed by repopulation with donated cells. Tomblyn et al. (2009) explain that disease is both targeted and eradicated by proxy through destroying the system of origin. The curative aim of treatment is for transplanted donor cells to manufacture a new disease-free blood supply within the recipient. Procedurally, blood and bone marrow transplant is provided through intravenous infusions of chemotherapy, supportive medications, fluids, and transfusions of blood products including donor cells. A central venous catheter (CVC) is one type of vascular access device that was specially developed for complex medical care by enabling long term use, exchange of large fluid volumes, and delivery of medications caustic to peripheral veins (Scales, 2010) . Patients describe a CVC as instrumental towards cure because it is the portal for delivering treatment (Møller & Adamsen, 2010) .
CVC care and management, as well as patient education, are primarily the responsibility of registered nurses in Canada. Given that risks are associated with using medical devices, patient safety is a central concern. Pneumothorax, infection, and thrombosis are examples of complications associated with CVC use (Kim et al., 2010; O'Grady et al., 2011) . Infection is of particular concern with the cell transplant population given their weakened immunity from disease and treatment (Tomblyn et al., 2009) . Nursing policy and procedures routinely incorporate study findings that correlate CVC care strategies with minimized risks. However, at present, there remain gaps in the evidence to support nursing practice in this area. Boersma and Schouten (2010) found that actual CVC practices vary across Europe as a manifestation of discrepant and/or absent practice guidelines. It is not known what the adherence to guidelines regarding CVC care is across Canada.
Several jurisdictions provide clinical practice guidelines for CVC competency including insertion, routine care, maintenance, and removal (Appendix A). The recommendations by O'Grady et al. (2011) are the most frequently cited in North America given open access via the American Centers for Disease Control and Prevention (CDC) and collaboration with several expert panels. Unresolved issues noted by O'Grady et al. (2011) point out gaps in the evidence concerning CVC care and management worth future research attention. Specific issues in blood and marrow transplant nursing described in the report are that no evidence-based recommendations can be made for optimal site selection for the catheter, optimal dressing type, removing the dressing from a healed tunnelled CVC site, or managing catheter patency. Periodic competency training is also encouraged with no clear stance on frequency. Policy makers and Registered Nurses are faced with distinguishing between conflicting recommendations and using practice-based approaches when evidence is lacking. The purpose of this descriptive study was to examine adherence to recommended CVC guidelines within the Canadian blood and marrow transplant population and identify potential nationwide variability in care strategies to be tested in future research.
Method
The study was approved by the institutional review board at the University of Texas at Tyler. As no other instrument existed, a descriptive survey was created for the purposes of this study, based on infection prevention guidelines for intravascular catheters by O'Grady et al. (2011) . The survey included 33 questions of inquiry in four areas related to the tunnelled CVC commonly used in blood and marrow transplant: insertion, routine care, maintenance, and removal. Survey questions contained various response options: yes or no choices, multiple choice, and open-ended formats. The survey was electronically distributed to 25 centres within the 14 blood cell and bone marrow transplant programs across Canada. A purposive sample of advanced practice nurses, nurse educators, managers, and program coordinators in blood and marrow transplant was invited to voluntarily answer questions regarding the CVC policy at their centre. One response per centre was accepted. A draw for a $50 gift card was used as an incentive for participation.
Results and interpretation
Thirteen respondents returned surveys and indicated provision of blood cell and/or bone marrow transplant at their centre (Appendix B). Three surveys were omitted from the analysis, as only the first two demographic questions were answered, for a total response rate of 40% (n=10). Responses included in the analysis represent both inpatient and outpatient settings treating adult (70%) and pediatric (40%) patients, seven of eight provinces offering blood and marrow transplant, and approximately 67% of the Canadian blood and marrow transplant population (Canadian Blood and Marrow Transplant Group, 2013).
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The survey results reveal that variations in CVC practice coincide with discrepant and/or absent guidelines in the areas of competency training, insertion, routine care, maintenance, and removal. CVC practice is reported as the duty of physicians and nurses with overlapping responsibility for insertion, dressing changes, and removal. Forty per cent of centres indicated that CVC care is also delegated to patients, family members, and lay caregivers. Competency in CVC care requires learning skills, the rationale for device use, and how to avoid complications. Studies recommend targeted education to maintain vigilance with care and avoid human error (Faruqi et al., 2012; Rosenthal, 2009 ). All survey respondents reported that their centre has a policy in place to educate staff on insertion, routine care, and maintenance of a CVC. All centres that delegate routine care reported having a policy in place for educating patients, families, and lay caregivers. Sixty per cent of centres repeat CVC education annually while the remaining centres only reinforce policy changes. Different educational strategies coincide with the subjective recommendation by O'Grady et al. (2011) to periodically evaluate knowledge and concordance with recommended guidelines.
Insertion
Survey responses indicate CVC insertion is a physician responsibility in the majority of cases and adherence is fully observed in avoiding prophylactic antibiotics, avoiding femoral veins, and using tunnelled or implanted catheters. Only one centre (10%) reported the use of antimicrobial impregnated cuffs which O'Grady et al. (2011) claim is only necessary with persistent infection in spite of prevention efforts. Instead, it is advised to employ multiple infection prevention strategies, known as bundling. CVC insertion bundling consists of: proper hand hygiene, using maximum barrier precautions (sterile gown, drape, gloves, equipment, and wearing a mask), using a >.5% chlorhexidine skin prep solution, choosing the appropriate site if known, and daily review of the necessity of the catheter with prompt removal when no longer essential (Faruqi et al., 2012; Moreau, 2009) . Supervision for inexperienced practitioners and use of ultrasound guidance is also recommended to reduce the risk of insertion-related complications (Shekelle et al., 2013) . In the survey results, adherence to bundling insertion strategies and use of ultrasound guidance was unknown by the responding nurses. Of note, the procedure is out of nursing practice scope in the majority of settings. The reported variation regarding insertion site selection coincides with the lack of evidence supporting subclavian over intra jugular sites, or one side of the body over the other (Ge et al., 2012) . Awareness of insertion guidelines is increasingly important given advanced practice nurses are beginning to engage in line placement (10%).
Routine care and maintenance
There is general consensus in the literature that a newly inserted CVC is covered with a dressing, not submerged in water, and has an extra covering for showering. However, the optimal dressing material to use remains unclear (Gillies, O'Riordan, Sheriff, & Rickard, 2011) . There is also consensus in the literature on the type of skin antiseptic to be used (>0.5% chlorhexidine or 70% alcohol, tincture of iodine, or iodophor for infants or allergies) and frequency of gauze or transparent dressing changes at 48 hours or after seven days respectively (Infusion Nurses Society, 2011; O'Grady et al., 2011; Scales, 2011) . All centres surveyed reported full adherence to recommendations specific to gauze or transparent materials and use of barriers and aseptic techniques for line care. However, 20% reported no additional protection is used for showering. Non-adherence to the recommendation may be due to the waterproof capability of a transparent dressing, which is the most commonly used material (90%) to cover a CVC exit site. Case studies report the elimination of water-borne bloodstream infection when using a waterproof covering for hygiene, even when a dressing is used on a CVC exit site, as the strategy provides added protection against colonization of caps and connections from tap water (Baird et al., 2011; Toscano et al., 2009 ).
Another variation in practice across Canada coincides with the discrepancy in views about maintaining or removing the dressing from a healed tunnelled exit site. The most recent Cochrane meta-analysis comparing dressing materials reported no study designed to draw comparisons with a "no dressing" group (Gillies et al., 2011) . Forty per cent of the centres surveyed in this study reported that healed tunnel sites are left open to air. The 2011 guidelines from the Infusion Nurses Society (INS) cite only one study supporting the no-dressing recommendation while the CDC remains irresolute on the issue.
Links between the inflammatory and coagulation response in the bloodstream interrelate infection and thrombosis (Levi, van der Poll, & Schultz, 2012) . The correlation of cumulative infection and thrombotic risks in cancer patients with a CVC highlights the importance of prevention strategies (Hitz et al., 2012; Rowan et al., 2013) . All centres reported CVC patency is maintained with normal saline flushing and heparin locking, though no centre used the same combinations or volumes. The INS (2011) defers maintenance decisions to instructions by product suppliers. Camp-Sorrell (2010) notes manufacturer recommendations continue to dictate care without providing current supportive evidence of product effectiveness versus complications. Varying volume and concentration types of locking solutions across Canada speak to the lack of guidance for preventing catheter occlusion which may, in turn, influence infection rates. Dibb et al. (2012) agree that maintaining the integrity of a CVC through the use of anticoagulants and antimicrobial locking solutions may be a feasible approach to preserving central access while admitting more evidence is needed. All respondents in this study reported that attempts are made to salvage sluggish and/or occluded lines with anticoagulants, and 60% indicated the use of anti-infective locking solutions are options for managing known infections. Practice guidelines for preventing infection do not speak to thrombotic correlations, do not advise anticoagulant use for the purpose of preventing catheter-related bloodstream infection, and caution against use of anti-infective locking solutions unless repeat infections are problematic (O'Grady et al., 2011) . Sodium citrate is one suggested multipurpose locking solution approved for use in Canada, though no centre in this survey reported use of the product (O'Grady et al., 2011).
Removal
Catheter-related infection, malfunction, or total occlusion may necessitate early line removal or replacement. Similar to insertion, CVC removal was reported in this study as primarily a physician responsibility with delegation to nurses in 20% of situations. Line removal is not recommended based on fever alone but is consistently advised for unnecessary catheters (INS, 2011; O'Grady et al., 2011; Tomblyn et al., 2009) . Twenty per cent of the centres do not adhere to prompt removal however results may be limited to the subjective interpretation of necessity by the nurses surveyed.
Discussion
The results of a descriptive survey of Canadian CVC practice support similar findings in Denmark and the Netherlands by Boersma and Schouten (2010) . When issues concerning CVC care remain unresolved in the literature, it poses clinical dilemmas for clinicians. Practice-based decisions often guide CVC care approaches when evidence is lacking or discrepant. Practice guidelines are not provided with the intent to replace clinical judgment, rather they serve to narrow variability when there is convincing evidence supporting certain care strategies over alternatives. Adherence to resolute guidelines depends on awareness of disseminated findings and time needed to incorporate findings into practice. Program accreditation is one option for ensuring minimum care standards within certain treatment areas. Regimented competency training may also ensure that diligence is maintained in practice. Care standards can only assist in mitigating risks when sufficient data are available.
Gaps in the evidence may lead to different care approaches being adopted that may result in differences in clinical effectiveness. Strengthening evidence through research is still needed in several aspects of CVC practice.
The plethora of available central venous access devices and variation in patient requirements for care points to the need for population-centred inquiries. Camp-Sorell (2010) notes that best practice is often identified through measuring systematic practices against outcomes. Studies comparing different CVC care approaches to infection and thrombosis rates may provide pragmatic resolutions to existing practice discrepancies. Measuring overlapping constructs contributes to a bank of insufficient findings that are often excluded from meta-analysis (Ge et al., 2012) . Examining specific vascular access devices within specific clinical populations should be considered for controlling construct validity. Variable practice and unresolved issues for recommendations point to the need for future dressing studies with tunnelled CVCs, including comparisons to a "no-dressing" group. Mathers (2011) notes the absence of standard flushing protocols for central access across America, which coincides with these survey results of Canadian practice. Empirical studies testing the effectiveness of particular flushing and locking solutions with specific devices in specific populations are needed for the development of practice guidelines.
Conclusion
Medical advances have allowed complex treatment for uncommon diseases. Central vascular access devices are commonplace in specialty areas treating acutely ill patients. Registered and Advanced Practice Nurses are in a position of positively influencing the incidence of complications with medical devices. Incongruent practice advice and gaps in evidence manifest in different care approaches worth research attention as variable practice may inadvertently propel disparate care. Results from the descriptive study of CVC practice across Canada indicate some centres do not fully adhere to all recommendations and that variable care approaches coincide with discrepant advice and gaps in evidence. Studies focusing on preventing catheter-related occlusions and infections have the potential to increase care quality. Incorporating the study of the cancer system capacity when investigating practice comparisons may provide additional validation of nursing influence.
